HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E N Knyazev Selected Research

MicroRNAs (MicroRNA)

7/2020Differences in the Drosha and Dicer Cleavage Profiles in Colorectal Cancer and Normal Colon Tissue Samples.
7/2020Factors Involved in miRNA Processing Change Its Expression Level during Imitation of Hypoxia in BeWo b30 Cells.
4/2018Expression of microRNA Genes MIR221, MIR222, and MIR181B1 Increases during Induction of Inflammation in the Endothelial Barrier Model.
9/2017hsa-miR-1973 MicroRNA is Significantly and Differentially Expressed in MDA-MB-231 Cells of Breast Adenocarcinoma and Xenografts Derived from the Tumor.
8/2017Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule.
4/2017Detection of Potential Metastatic Prostate Cancer Circulating Biomarkers by Comparison of miRNA Profiles in DU145 Cells and Culture Medium.
1/2017Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer.
5/2016MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer.
5/2016Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer.
4/2016Analysis of Plasma microRNA Associated with Hemolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E N Knyazev Research Topics

Disease

6Neoplasms (Cancer)
09/2018 - 08/2013
6Prostatic Neoplasms (Prostate Cancer)
08/2017 - 08/2015
4Hypoxia (Hypoxemia)
07/2021 - 01/2019
3Choriocarcinoma
07/2021 - 01/2019
2Adenocarcinoma
07/2020 - 09/2017
2Hemolysis
05/2016 - 04/2016
1Inflammation (Inflammations)
04/2018
1Pre-Eclampsia (Preeclampsia)
04/2018
1Genomic Instability
04/2017
1Neoplasm Metastasis (Metastasis)
05/2016
1Hyperplasia
05/2016
1Melanoma (Melanoma, Malignant)
04/2016
1Nevus (Nevi)
04/2016
1Hypotension (Low Blood Pressure)
12/2014

Drug/Important Bio-Agent (IBA)

10MicroRNAs (MicroRNA)IBA
07/2020 - 04/2016
3Oxyquinoline (8 Hydroxyquinoline)FDA Link
07/2020 - 01/2019
3Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
07/2020 - 01/2019
2Biomarkers (Surrogate Marker)IBA
09/2018 - 04/2017
2Circulating MicroRNAIBA
08/2017 - 05/2016
2Small Interfering RNA (siRNA)IBA
04/2016 - 08/2015
1Mechanistic Target of Rapamycin Complex 1IBA
07/2021
1cobaltous chloride (cobalt(II)chloride)IBA
07/2021
1EnzymesIBA
07/2020
1Protein Isoforms (Isoforms)IBA
07/2020
1fluorescein isothiocyanate dextranIBA
01/2019
1Laminin (Merosin)IBA
09/2018
1OsteonectinIBA
09/2018
1CollagenIBA
09/2018
1Capsules (Microcapsules)IBA
08/2017
1human MIRN3175 microRNAIBA
04/2017
1human MIRN297 microRNAIBA
01/2017
1human MIRN4674 microRNAIBA
05/2016
1human MIRN1184 microRNAIBA
05/2016
1AntigensIBA
04/2016
1human MIRN107 microRNAIBA
04/2016
1Monoclonal AntibodiesIBA
04/2016
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
04/2016
1IntegrinsIBA
08/2015
1Nitric Oxide Synthase (NO Synthase)IBA
12/2014
1Cytostatic AgentsIBA
08/2013
1Antineoplastic Agents (Antineoplastics)IBA
08/2013
1Trastuzumab (Herceptin)FDA Link
08/2013

Therapy/Procedure

1Therapeutics
08/2013